Consequently, the aim of this meta-analysis was to evaluate the efficacy and safety of pretreatment with antidepressants to prevent IFN-α/RBV-associated depression in patients with CHC treated with antiviral therapy in randomized, double-blind, placebo-controlled trials. This evidence concerns the gene IFNA17 and depressive symptom measurement.